Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 216

Results For "X"

9471 News Found

Sanofi India appoints Rahul Bhatnagar as Chairman of Board of Directors
People | May 03, 2026

Sanofi India appoints Rahul Bhatnagar as Chairman of Board of Directors

Rahul Bhatnagar succeeds Aditya Narayan, who completed a decade-long distinguished tenure


FDA grants breakthrough status to Laguna's mRNA blood test for schizophrenia diagnosis
News | May 02, 2026

FDA grants breakthrough status to Laguna's mRNA blood test for schizophrenia diagnosis

The move puts a spotlight on one of psychiatry’s most persistent clinical challenges: misdiagnosis and delay


FDA renews IQOS “reduced-risk” status backing PMI’s smoke-free strategy in regulatory win
News | May 02, 2026

FDA renews IQOS “reduced-risk” status backing PMI’s smoke-free strategy in regulatory win

The renewal covers two versions of the IQOS device and three HEETS tobacco variants


Bayer pushes stroke prevention drug forward in China as regulators accept key filing
News | May 02, 2026

Bayer pushes stroke prevention drug forward in China as regulators accept key filing

Stroke is the second-leading cause of death and the third-leading cause of disability worldwide


IMCD posts steady Q1 2026 performance with €130 million EBITA amid global uncertainty
Supply Chain | May 02, 2026

IMCD posts steady Q1 2026 performance with €130 million EBITA amid global uncertainty

The company posted revenue of €1,267 million, up 6% on a constant currency basis


Thermo Fisher opens flagship US Bioprocess Design Center in Massachusetts
R&D | May 02, 2026

Thermo Fisher opens flagship US Bioprocess Design Center in Massachusetts

The 4,000-square-foot facility is designed as a hands-on hub where customers can work directly with scientists and engineers


Thermo Fisher to sell microbiology business in $1.075 billion deal with Astorg
News | May 02, 2026

Thermo Fisher to sell microbiology business in $1.075 billion deal with Astorg

The microbiology unit generated $645 million in revenue in 2025 and sits within Thermo Fisher’s Specialty Diagnostics segment


Dr Lal PathLabs posts strong Q4 FY26 results with 16.6% revenue growth & PAT at Rs. 132 Cr
News | May 02, 2026

Dr Lal PathLabs posts strong Q4 FY26 results with 16.6% revenue growth & PAT at Rs. 132 Cr

The company posted revenue of Rs. 703 crore in Q4 FY26


Aster DM Healthcare surges in Q4
News | May 02, 2026

Aster DM Healthcare surges in Q4

Merger momentum builds as profits jump


Patient-centric innovation driving fight against neglected diseases: Sanjay Sarin, Continental Lead Asia and South Asia Director, DNDi
interviews | May 01, 2026

Patient-centric innovation driving fight against neglected diseases: Sanjay Sarin, Continental Lead Asia and South Asia Director, DNDi

While Drugs for Neglected Diseases initiative (DNDi) drives the R&D for neglected diseases, we collaborate with pharmaceutical companies at multiple stages, including sourcing promising molecules